Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell TherapyBusiness Wire • 06/17/24
Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research AlternativesBusiness Wire • 06/11/24
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in SomervilleBusiness Wire • 06/06/24
Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in ResearchBusiness Wire • 06/04/24
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy DevelopmentBusiness Wire • 05/30/24
Titian Receives Multi-Year Commitment from Charles River for Mosaic Sample Management SoftwareBusiness Wire • 05/28/24
Don't Overlook Charles River (CRL) International Revenue Trends While Assessing the StockZacks Investment Research • 05/13/24
Charles River (CRL) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 05/09/24
Charles River (CRL) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresZacks Investment Research • 05/06/24
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMPBusiness Wire • 05/02/24
Charles River Laboratories Achieves 100% Renewable Electricity Usage GloballyBusiness Wire • 04/22/24
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal TestingBusiness Wire • 04/16/24